S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
Log in

Cardiovascular Systems Stock Forecast, Price & News

-0.99 (-2.17 %)
(As of 01/15/2021 12:00 AM ET)
Today's Range
Now: $44.67
50-Day Range
MA: $41.01
52-Week Range
Now: $44.67
Volume226,591 shs
Average Volume259,929 shs
Market Capitalization$1.79 billion
P/E RatioN/A
Dividend YieldN/A
Cardiovascular Systems, Inc., a medical device company, develops and commercializes various devices to treat peripheral and coronary artery diseases in the United States. The company offers peripheral artery disease products, which are catheter-based platforms to treat a range of plaque types in above and below the knee leg arteries, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products. It also provides Diamondback 360 Coronary orbital atherectomy systems (OAS), a coronary artery disease (CAD) product designed to facilitate stent delivery in patients with CAD who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to severely calcified coronary artery lesions. The company was founded in 1989 and is headquartered in St. Paul, Minnesota.
Cardiovascular Systems logo


Overall MarketRank

1.28 out of 5 stars

Medical Sector

632nd out of 1,558 stocks

Surgical & Medical Instruments Industry

69th out of 137 stocks

Analyst Opinion: 1.5Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
Current SymbolNASDAQ:CSII



Sales & Book Value

Annual Sales$236.54 million
Book Value$7.62 per share


Net Income$-27,240,000.00


Market Cap$1.79 billion
Next Earnings Date2/3/2021 (Confirmed)
-0.99 (-2.17 %)
(As of 01/15/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CSII News and Ratings via Email

Sign-up to receive the latest news and ratings for CSII and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Cardiovascular Systems (NASDAQ:CSII) Frequently Asked Questions

How has Cardiovascular Systems' stock price been impacted by COVID-19?

Cardiovascular Systems' stock was trading at $36.32 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, CSII stock has increased by 23.0% and is now trading at $44.67.
View which stocks have been most impacted by COVID-19

Is Cardiovascular Systems a buy right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cardiovascular Systems in the last twelve months. There are currently 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Cardiovascular Systems stock.
View analyst ratings for Cardiovascular Systems
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Cardiovascular Systems?

Wall Street analysts have given Cardiovascular Systems a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Cardiovascular Systems wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Cardiovascular Systems' next earnings date?

Cardiovascular Systems is scheduled to release its next quarterly earnings announcement on Wednesday, February 3rd 2021.
View our earnings forecast for Cardiovascular Systems

How can I listen to Cardiovascular Systems' earnings call?

Cardiovascular Systems will be holding an earnings conference call on Wednesday, February 3rd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Cardiovascular Systems' earnings last quarter?

Cardiovascular Systems, Inc. (NASDAQ:CSII) released its quarterly earnings data on Wednesday, November, 4th. The medical device company reported ($0.05) earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of ($0.23) by $0.18. The medical device company had revenue of $60.54 million for the quarter, compared to analyst estimates of $56.27 million. Cardiovascular Systems had a negative return on equity of 11.43% and a negative net margin of 10.12%.
View Cardiovascular Systems' earnings history

What guidance has Cardiovascular Systems issued on next quarter's earnings?

Cardiovascular Systems updated its second quarter 2021 After-Hours earnings guidance on Wednesday, November, 4th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $63-67 million, compared to the consensus revenue estimate of $66.01 million.

What price target have analysts set for CSII?

7 brokerages have issued 12-month target prices for Cardiovascular Systems' stock. Their forecasts range from $45.00 to $50.00. On average, they expect Cardiovascular Systems' share price to reach $47.00 in the next year. This suggests a possible upside of 5.2% from the stock's current price.
View analysts' price targets for Cardiovascular Systems
or view Wall Street analyst' top-rated stocks.

Are investors shorting Cardiovascular Systems?

Cardiovascular Systems saw a increase in short interest in the month of December. As of December 31st, there was short interest totaling 1,400,000 shares, an increase of 41.2% from the December 15th total of 991,400 shares. Based on an average daily trading volume, of 292,300 shares, the short-interest ratio is presently 4.8 days.
View Cardiovascular Systems' Short Interest

Who are some of Cardiovascular Systems' key competitors?

What other stocks do shareholders of Cardiovascular Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardiovascular Systems investors own include Gilead Sciences (GILD), AbbVie (ABBV), Advanced Micro Devices (AMD), Medtronic (MDT), Pfizer (PFE), (XEL), ACADIA Pharmaceuticals (ACAD), Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK) and The Procter & Gamble (PG).

Who are Cardiovascular Systems' key executives?

Cardiovascular Systems' management team includes the following people:
  • Mr. Scott Raymond Ward M.S., MS, B.Sc., Chairman, Pres & CEO (Age 60, Pay $1.17M)
  • Mr. Jeffrey S. Points, Chief Financial Officer (Age 43, Pay $507.49k)
  • Ms. Rhonda J. Robb, Chief Operating Officer (Age 52, Pay $830.22k)
  • Mr. Alexander Rosenstein, Gen. Counsel & Corp. Sec. (Age 48, Pay $523.26k)
  • Dr. Ryan D. Egeland M.D., Ph.D., Chief Medical Officer (Age 45, Pay $490.64k)
  • Mr. John E. Nielsen, VP of Investor Relations & Corp. Communications
  • Ms. Sandra M. Sedo, Chief Compliance Officer (Age 56)
  • Mr. David S. Whitescarver, VP of Corp. Devel. & Intellectual Property (Age 62)
  • Mr. Stephen J. Rempe, Chief HR Officer (Age 47)

What is Cardiovascular Systems' stock symbol?

Cardiovascular Systems trades on the NASDAQ under the ticker symbol "CSII."

Who are Cardiovascular Systems' major shareholders?

Cardiovascular Systems' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include State of Alaska Department of Revenue (0.08%) and Diversified Trust Co (0.04%). Company insiders that own Cardiovascular Systems stock include Alexander Rosenstein, Erik Paulsen, Martha Goldberg Aronson, Rhonda J Robb and Sandra Sedo.
View institutional ownership trends for Cardiovascular Systems

Which major investors are selling Cardiovascular Systems stock?

CSII stock was sold by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue. Company insiders that have sold Cardiovascular Systems company stock in the last year include Alexander Rosenstein, and Sandra Sedo.
View insider buying and selling activity for Cardiovascular Systems
or view top insider-selling stocks.

Which major investors are buying Cardiovascular Systems stock?

CSII stock was purchased by a variety of institutional investors in the last quarter, including Diversified Trust Co. Company insiders that have bought Cardiovascular Systems stock in the last two years include Erik Paulsen, Martha Goldberg Aronson, and Rhonda J Robb.
View insider buying and selling activity for Cardiovascular Systems
or or view top insider-buying stocks.

How do I buy shares of Cardiovascular Systems?

Shares of CSII can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Cardiovascular Systems' stock price today?

One share of CSII stock can currently be purchased for approximately $44.67.

How big of a company is Cardiovascular Systems?

Cardiovascular Systems has a market capitalization of $1.79 billion and generates $236.54 million in revenue each year. The medical device company earns $-27,240,000.00 in net income (profit) each year or ($0.79) on an earnings per share basis. Cardiovascular Systems employs 779 workers across the globe.

What is Cardiovascular Systems' official website?

The official website for Cardiovascular Systems is www.csi360.com.

How can I contact Cardiovascular Systems?

Cardiovascular Systems' mailing address is 1225 OLD HWY 8 NW, ST. PAUL MN, 55112. The medical device company can be reached via phone at 651-259-1600 or via email at [email protected]

This page was last updated on 1/17/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.